Dr. Reddy's Laboratories Ltd has received tentative approval from the U.S. Food and Drug Administration for heartburn drug pantoprazole sodium

Dr Reddys Laboratories 's principal activity is to manufacture and market pharmaceutical products. The Group operates in seven segments: Generics, Active Pharmaceutical Ingredients and Intermediates, Formulations, Critical Care and Biotechnology, Custom Pharmaceutical Services, Drug Discovery and Other. The Group markets its products to North America, Russia and other CIS countries, Europe and other countries.